As part of a succession plan, Verium investors together with the management team acquire a majority shareholding in Zünd Precision Optics and Optivac (together “Zünd Group"). René Zünd retains a significant minority stake and continues to be involved in the company, thus ensuring continuity and a smooth transition. Post transaction, the company’s board will be strengthened with Damian Stricker, George Merk and Christian Velez, who has many years of experience in the industry and is the founder and CEO of Exalos.
The Group currently employs around 65 highly skilled employees and has a state-of-the-art production facility in Diepoldsau. The company has a strong market position in its technically demanding niche and differentiates itself through quality leadership, long-standing technological expertise and a strong customer focus.
Verium is convinced that, together with Zünd`s motivated employees and experienced management team, the coherent growth strategy can be continued and existing market opportunities exploited. In particular, the continuing trend towards minimally invasive surgery with robotics will certainly open up further potentials for the company.
Marc Erni, Managing Partner and Head of Private Equity Verium, firstname.lastname@example.org
Damian Stricker, Head of Value Creation Verium, email@example.com
Stephanie Buschle, Investment Director Verium, firstname.lastname@example.org
George Merk, Investment Director Verium, email@example.com
Severin Stefanini, Investment Analyst Verium, firstname.lastname@example.org